Assessing MedTech Impact From Potential China Tariffs
Kepler Capital Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Fresenius Medical Q3 Earnings Beat Estimates, Operating Margin Rises
Truist Financial Maintains Fresenius Medical Care(FMS.US) With Hold Rating, Maintains Target Price $23
Analysts Offer Insights on Healthcare Companies: Merus (MRUS), Fresenius Medical Care (FMS) and Treace Medical Concepts (TMCI)
Berenberg Bank Initiates Fresenius Medical Care(FMS.US) With Buy Rating, Announces Target Price $25.6
Fresenius Medical Care AG & Co. KGaA (0H9X) Gets a Hold From UBS
Fresenius Medical Care (ETR:FME) Is Finding It Tricky To Allocate Its Capital
Fresenius Medical Care AG (FMS) Q3 2024 Earnings Call Transcript Summary
Fresenius Medical Care Unveils New Long-Term Incentive Plan
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday as US Heads to Polls for 2024 Presidential Elections
Fresenius Medical Care Q3 Earnings Rise, Revenue Decreases
Fresenius Medical Care 3Q EPS EUR0.73 >FMS
Press Release: Fresenius Medical Care Reports Strong Operating Income Margin Growth in the Third Quarter of 2024
6-K: Report of foreign private issuer (related to financial reporting)
Fresenius Medical Care Q3 2024 Adj EPS €0.73 May Not Be Comparable To €0.35 Estimate, Sales €4.76B Miss €4.89B Estimate
Bernstein Sticks to Their Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Buy From Berenberg Bank
Global Equities Roundup: Market Talk
Fresenius Medical Care's Results Show Portfolio Optimization Is on Track -- Market Talk
No Data
No Data